Clinical Trials Browser

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

NCT02178436 2023-11-07

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Phase 1/2 Completed

15 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02333188 2023-05-31

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Phase 1 Completed

50 enrolled

Gastrointestinal

Gallbladder Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT02620865 2023-05-15

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Phase 1/2 Completed

2 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03410030 2023-04-18

AA NABPLAGEM

Phase 1/2 Completed

27 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02707159 2023-03-08

PACT-ACT-v6

Phase 2 Completed

70 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT02762981 2022-12-06

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

Phase 1/2 Completed

85 enrolled 24 charts

BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT02227940 2022-07-25

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Phase 1 Completed

38 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00031694 2021-06-11

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Phase 2 Completed

19 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02155088 2021-04-08

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Phase 1 Completed

15 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT00026104 2020-10-30

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 2 Completed

154 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04133155 2020-03-13

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Completed

103 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02358161 2020-01-09

MATRIX

Phase 1/2 Completed

78 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01280058 2018-03-09

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Phase 2 Completed

73 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00691054 2017-05-11

Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy

Phase 2 Completed

20 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01161186 2012-10-11

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma

Phase 1 Completed

15 enrolled

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Clinical Trials

NABPLAGEMD

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

PINBALL

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

PAAG

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

AA NABPLAGEM

PACT-ACT-v6

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

MATRIX

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma